enow.com Web Search

  1. Ads

    related to: trazodone dailymed dosage for sleep

Search results

  1. Results from the WOW.Com Content Network
  2. Trazodone - Wikipedia

    en.wikipedia.org/wiki/Trazodone

    Still, trazodone is often helpful for geriatric patients with depression who have severe agitation and insomnia. [27] Trazodone is usually used at a dosage of 150 to 300 mg/day for the treatment of depression. [17] [13] Lower doses have also been used to augment other antidepressants or when initiating therapy.

  3. Zaleplon - Wikipedia

    en.wikipedia.org/wiki/Zaleplon

    Zaleplon significantly reduces the time required to fall asleep by improving sleep latency and may therefore facilitate sleep induction rather than sleep maintenance. [ 12 ] [ 13 ] [ 14 ] Due to its ultrashort elimination half-life, zaleplon may not be effective in reducing premature awakenings; however, it may be administered to alleviate ...

  4. List of adverse effects of trazodone - Wikipedia

    en.wikipedia.org/wiki/List_of_adverse_effects_of...

    This is a list of adverse effects of the antidepressant trazodone, sorted by frequency of occurrence. [1] [2] [3] ... Insomnia; Dream disorder; Disorientation ...

  5. 5 Best CBD Products for Sleep - AOL

    www.aol.com/lifestyle/5-best-cbd-products-sleep...

    The National Sleep Foundation recommends that healthy adults get between seven and nine hours a night. The scientific jury is still out when it comes to sleep in general and sleep conditions like ...

  6. Serotonin antagonist and reuptake inhibitor - Wikipedia

    en.wikipedia.org/wiki/Serotonin_antagonist_and...

    Niaprazine (Nopron) – a drug related to this group but does not inhibit the reuptake of serotonin or the other monoamines. Medifoxamine (Clédial, Gerdaxyl) – could perhaps technically be said to belong to this group, as it is a serotonin–dopamine reuptake inhibitor and 5-HT 2A and 5-HT 2C receptor antagonist, but not grouped as such. [1]

  7. Tasimelteon - Wikipedia

    en.wikipedia.org/wiki/Tasimelteon

    A phase III insomnia trial was conducted in 2006. [12] A second phase III trial on insomnia, this time concerning primary insomnia, was completed in June 2008. [13] In 2010, the FDA granted orphan drug status to tasimelteon, then regarded as an investigational medication, for use in totally blind adults with N24HSWD. [14] (Through mechanisms ...

  1. Ads

    related to: trazodone dailymed dosage for sleep